LANDONI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 8.554
EU - Europa 3.725
AS - Asia 1.286
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Totale 13.582
Nazione #
US - Stati Uniti d'America 8.420
IT - Italia 858
SE - Svezia 670
CN - Cina 582
IE - Irlanda 470
DE - Germania 454
UA - Ucraina 424
SG - Singapore 403
RU - Federazione Russa 316
GB - Regno Unito 212
HK - Hong Kong 159
CA - Canada 129
FI - Finlandia 105
FR - Francia 84
VN - Vietnam 50
DK - Danimarca 30
IN - India 27
TR - Turchia 25
NL - Olanda 24
AT - Austria 21
BE - Belgio 20
TH - Thailandia 20
CZ - Repubblica Ceca 12
PL - Polonia 10
IR - Iran 7
JP - Giappone 6
CH - Svizzera 5
EU - Europa 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 2
BR - Brasile 2
ES - Italia 2
ID - Indonesia 2
KR - Corea 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
IL - Israele 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
ZA - Sudafrica 1
Totale 13.582
Città #
Ann Arbor 1.758
Woodbridge 828
Houston 783
Fairfield 704
Chandler 588
Jacksonville 482
Dublin 448
Wilmington 387
Ashburn 343
Singapore 339
Frankfurt am Main 320
Dearborn 318
Seattle 273
Cambridge 215
Milan 196
New York 189
Princeton 188
Santa Clara 180
Hong Kong 159
Nanjing 126
Lissone 110
Shanghai 90
Lawrence 89
Altamura 80
Lachine 78
Boardman 58
Beijing 48
Guangzhou 44
San Diego 37
Dong Ket 33
Nanchang 33
Shenyang 33
Falls Church 32
Andover 31
Fremont 27
Changsha 26
Mountain View 23
Helsinki 22
Jinan 22
Ottawa 22
Vienna 21
Bangkok 20
Huizen 20
Dallas 19
London 19
Monza 19
Philadelphia 19
Brussels 18
Hebei 18
Toronto 18
Jiaxing 16
Tianjin 16
Zhengzhou 15
Spoltore 14
Norwalk 13
Rome 13
Genoa 12
Paris 12
Ningbo 11
Segrate 11
University Park 11
Kunming 10
Orzinuovi 10
Brno 9
Hefei 9
Munich 9
Pune 9
Kraków 8
Los Angeles 8
Naples 8
Redmond 8
Taizhou 8
Auburn Hills 7
Kilburn 6
Lecco 6
Montréal 6
Edmonton 5
Florence 5
Haikou 5
Hangzhou 5
Kiev 5
Leawood 5
Plaisir 5
San Mateo 5
Sesto San Giovanni 5
Tappahannock 5
Alessandria 4
Bari 4
Chicago 4
Gorgonzola 4
Hounslow 4
Kocaeli 4
Laurel 4
Orta di Atella 4
Piacenza 4
Washington 4
Wuhan 4
Canneto sull'Oglio 3
Chions 3
Como 3
Totale 10.321
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 374
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 317
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 315
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 310
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 305
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 282
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 237
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 228
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 213
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 204
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 203
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 196
Evaluation of time of flight (TOF) and point spread function (PSF) reconstructions in the quantification of myocardial blood flow with 13N ammonia and PET: Comparison among reconstructions (reprojection, OSEM), software (PMOD and CARIMAS) and operators 196
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 195
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 193
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 192
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 185
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 179
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 179
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 178
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 171
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 171
[(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging 168
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 168
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 164
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 164
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 164
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers 162
Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction 162
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 160
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 157
Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography 156
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 155
Relation between myocardial 18F-FDG uptake in the fasting state and coronary angiography in patients with coronary artery disease 155
Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study 149
An automatic classification technique for attenuation correction in positron emission tomography 149
Positive [11c]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer 149
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 148
A procedure for wall detection in [18F]FDG positron emission tomography heart studies 146
Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy 145
Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability 145
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer 143
Multifocal, persistent cardiac uptake of [18-F]-Fluoro-Deoxy-Glucose detected by positron emission tomography in patients with acute myocardial infarction 140
Evaluation of the clinical performances of a large Nal(TI) crystal 3D PET scanner 139
Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography 139
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 137
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: Case report and literature review 137
Spatial registration of echocardiographic and positron emission tomographic heart studies 137
A simplified method to integrate metabolic images in stereotactic procedures using a PET/CT scanner 137
Role of Computed Tomography and 18F-Fluorodeoxyglucose Positron Emission Tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation 136
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results 133
Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG Positron Emission Tomography 132
Target volume definition for stereotactic radiotherapy of lung metastases: A comparison between PET/CT and 4D-PET/CT 131
18-FDG positron emission tomography in the evaluation of malignant pleural diseases - A pilot study 128
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 128
Correlation of SPECT and PET cardiac images by a surface matching registration technique 127
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up 127
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma 126
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 125
Identification of hibernating myocardium: A comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction 125
Automatic integration of PET/CT images for clinical use in radiotherapy 124
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 123
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability 119
New radiopharmaceuticals and imaging of the heart receptors 119
Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis - a possible unique pathophysiological mechanism 116
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 116
A procedure for patient repositioning and compensation for misalignment between transmission and emission data in PET heart studies 116
Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? 110
Application of a surface matching image registration technique to the correlation of cardiac studies in positron emission tomography (PET) by transmission images 110
Molecular imaging in prostate cancer: [11C]choline PET/CT 109
Glucose metabolism and pathological findings in uveal melanoma preliminary results 108
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography 108
Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function 106
Feasibility of [F-18]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer 106
Helical tomotherapy for scalp recurrence of primary eccrine mucinous adenocarcinoma 103
Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: Comparison with the distribution of [18F]FDG assessed by PET 103
PET-CT and breast cancer 102
Two dimensional vs three-dimentional imaging in whole boby oncologic PET/CT: A discovery-STE phantom and patient study 99
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 98
PET/CT in diagnostic oncology 98
Abnormal myocardial glucose handling in patients with syndrome X: Effect of beta-adrenergic blockade 93
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 93
Clinical application of 11C-Choline PET in patients with biochemical relapse of prostate cancer 87
PET/CT and breast cancer 87
Advanced ovarian carcinoma: Usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment 86
Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201Tl rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction 85
Increased [11C]Choline uptake in bronchioalveolar cell carcinoma with negative [18F]FDG uptake. A PET/CT and pathology study 78
Rapid spread of PET in workup of cancer - But Sweden lags behind [Snabb ökning av PET i utredning av cancer - Men sverige släpar efter] 77
Ruolo della tomografia ad emissione di positroni nella caratterizzazione dei noduli solitari polmonari indeterminati 73
PET-Guided target delineation in a patient with lung cancer. 72
Regional glucose utilization in infarcted and remote myocardium: Its relation to coronary anatomy and perfusion 70
Comparison of dual-head coincidence PET versus ring PET in tumor patients 61
Correction measured by attenuation in tomographic heart studies with single photon emission with thallium 201. Comparison with positron- emission tomographic studies with ammonium marked with nitrogen 58
Imaging myocardial innervation in congestive heart failure: methods and clinical implications 54
Tomoterapia ed ipofrazionamento 52
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 33
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 31
Totale 13.899
Categoria #
all - tutte 45.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.592 0 0 0 0 229 303 330 182 260 88 153 47
2020/20211.770 97 68 181 199 151 129 164 169 162 193 103 154
2021/20221.327 90 170 153 145 71 71 74 79 64 74 135 201
2022/20232.265 268 607 174 250 177 367 18 96 163 43 79 23
2023/20241.392 67 54 81 64 192 371 271 36 71 21 29 135
2024/20251.064 176 473 165 138 112 0 0 0 0 0 0 0
Totale 13.899